| Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes M Gal‐Tanamy, L Bachmetov, A Ravid, R Koren, A Erman, R Tur‐Kaspa, ... Hepatology 54 (5), 1570-1579, 2011 | 240 | 2011 |
| Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity L Bachmetov, M Gal‐Tanamy, A Shapira, M Vorobeychik, ... Journal of viral hepatitis 19 (2), e81-e88, 2012 | 223 | 2012 |
| Definition of a conserved immunodominant domain on hepatitis C virus E2 glycoprotein by neutralizing human monoclonal antibodies ZY Keck, TK Li, J Xia, M Gal-Tanamy, O Olson, SH Li, AH Patel, JK Ball, ... Journal of virology 82 (12), 6061-6066, 2008 | 148 | 2008 |
| Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals S Perez, A Kaspi, T Domovitz, A Davidovich, A Lavi-Itzkovitz, T Meirson, ... PLoS genetics 15 (6), e1008181, 2019 | 142 | 2019 |
| Vaccines for biodefense and emerging and neglected diseases ADT Barrett, LR Stanberry Academic Press, 2009 | 118 | 2009 |
| In vitro selection of a neutralization-resistant hepatitis C virus escape mutant M Gal-Tanamy, ZY Keck, MK Yi, JA McKeating, AH Patel, SKH Foung, ... Proceedings of the National Academy of Sciences 105 (49), 19450-19455, 2008 | 97 | 2008 |
| Lower serologic response to COVID-19 mRNA vaccine in patients with inflammatory bowel diseases treated with anti-TNFα H Edelman-Klapper, E Zittan, ABG Shitrit, KM Rabinowitz, I Goren, ... Gastroenterology 162 (2), 454-467, 2022 | 85 | 2022 |
| A point mutation leading to hepatitis C virus escape from neutralization by a monoclonal antibody to a conserved conformational epitope ZY Keck, O Olson, M Gal-Tanamy, J Xia, AH Patel, M Dreux, FL Cosset, ... Journal of virology 82 (12), 6067-6072, 2008 | 70 | 2008 |
| BNT162b2 mRNA vaccine elicited antibody response in blood and milk of breastfeeding women M Rosenberg-Friedman, A Kigel, Y Bahar, M Werbner, J Alter, Y Yogev, ... Nature Communications 12 (1), 6222, 2021 | 69 | 2021 |
| Pseudoviruses for the assessment of coronavirus disinfection by ozone I Zucker, Y Lester, J Alter, M Werbner, Y Yecheskel, M Gal-Tanamy, ... Environmental chemistry letters 19, 1779-1785, 2021 | 50 | 2021 |
| Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors M Mor, M Werbner, J Alter, M Safra, E Chomsky, JC Lee, S Hada-Neeman, ... PLoS Pathogens 17 (2), e1009165, 2021 | 43 | 2021 |
| Removal of hepatitis C virus-infected cells by a zymogenized bacterial toxin A Shapira, S Shapira, M Gal-Tanamy, R Zemel, R Tur-Kaspa, I Benhar PloS one 7 (2), e32320, 2012 | 40 | 2012 |
| Antibody repertoire analysis of hepatitis C virus infections identifies immune signatures associated with spontaneous clearance S Eliyahu, O Sharabi, S Elmedvi, R Timor, A Davidovich, F Vigneault, ... Frontiers in immunology 9, 3004, 2018 | 35 | 2018 |
| Hepatitis C virus enhances the invasiveness of hepatocellular carcinoma via EGFR-mediated invadopodia formation and activation L Ninio, A Nissani, T Meirson, T Domovitz, A Genna, S Twafra, ... Cells 8 (11), 1395, 2019 | 30 | 2019 |
| Inhibition of hepatitis C virus RNA replicons by peptide aptamers A Trahtenherts, M Gal-Tanamy, R Zemel, L Bachmatov, S Loewenstein, ... Antiviral research 77 (3), 195-205, 2008 | 30 | 2008 |
| Tracking down the epigenetic footprint of HCV-induced hepatocarcinogenesis T Domovitz, M Gal-Tanamy Journal of Clinical Medicine 10 (3), 551, 2021 | 27 | 2021 |
| HCV NS3 serine protease-neutralizing single-chain antibodies isolated by a novel genetic screen M Gal-Tanamy, R Zemel, Y Berdichevsky, L Bachmatov, R Tur-Kaspa, ... Journal of molecular biology 347 (5), 991-1003, 2005 | 21 | 2005 |
| Single chain antibodies specific for fatty acids derived from a semi-synthetic phage display library A Gargir, I Ofek, S Meron-Sudai, MG Tanamy, PS Kabouridis, A Nissim Biochimica et Biophysica Acta (BBA)-General Subjects 1569 (1-3), 167-173, 2002 | 21 | 2002 |
| Inhibition of protease-inhibitor-resistant hepatitis C virus replicons and infectious virus by intracellular intrabodies M Gal-Tanamy, R Zemel, L Bachmatov, RK Jangra, A Shapira, ... Antiviral research 88 (1), 95-106, 2010 | 18 | 2010 |
| Protease inhibitors and method of screening thereof I Benhar, R Tur-Kaspa, R Zemel, M Gal-Tanamy, A Trachtenherz, ... US Patent App. 11/839,301, 2008 | 17 | 2008 |
